Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we would like to inform you that a meeting of Board of Directors of was held today i.e ....

Venmax Drugs and Pharmaceuticals Ltd has announced the outcome of its Board Meeting, which included the approval of the Notice and Directors Report for the Financial Year 2025-2026, Secretarial Audit Report, and the date, time, and venue of the 37th Annual General Meeting. The Board also approved the appointment of Mr. Venkata Rao Sadhanala as Managing Director and the regularization of Mrs. Padmaja Kalyani Sadhanala and Mr. Revoor Ramachandra as Non-Executive Directors.